During the past decade, Centro Oncologico de Galicia conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 24 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 14 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Oncologico de Galicia" #1 sponsor was "Spanish Breast Cancer Research Group" with 18 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 3 trials sponsored, "Grupo Espanol Multidisciplinario del Cancer Digestivo" with 3 trials sponsored and "MedSIR" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Oncologico de Galicia" #1 collaborator was "Hoffmann-La Roche" with 8 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Pfizer" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator and "Amgen" with 3 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Centro Oncologico de Galicia" are "Breast Cancer" (24 trials), "Breast Neoplasms" (4 trials), "Advanced Breast Cancer" (3 trials), "Advanced Prostate Cancer" (3 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Centro Oncologico de Galicia" in a lesser frequency.

Most popular intervention types in "Centro Oncologico de Galicia" are "Drug" (58 trials), "Other" (3 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (10 trials), "Trastuzumab" (10 trials), "Paclitaxel" (9 trials), "Capecitabine" (6 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Centro Oncologico de Galicia" are 33 trials for "All" genders, 31 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Oncologico de Galicia". undefined are not yet recruiting, 7 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Centro Oncologico de Galicia, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Oncologico de Galicia, 3 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".